🇮🇪Ireland
16°C Partly Cloudy · Dublin
Live Updates
--:--:-- IST
Contributor sign in
Latest
Clinical Trials in Germany / NCT04064450
Active, not recruiting Observational

MyoVasc Study on the Development and Progression of Heart Failure

NCT04064450 · tracked via the Priya Life Science Germany tracker
Phase
Observational
Started
2013-01
Last updated
2024-08-22

Condition(s) studied

Heart Failure

Study summary

The MyoVasc - Study is an observational, prospective cohort study. The study is investigating the development and progression of the heart failure syndrome, phenotypes of the heterogeneous syndrome, and the interactions of phenotypes with the vasculature regarding their impact for the course of heart failure.

Eligibility

Sex
ALL
Min age
35 Years
Max age
84 Years
Healthy volunteers
Accepted
Inclusion Criteria: * Asymptomatic heart failure or symptomatic heart failure * Written consent * Sufficient knowledge of the German language, in order to understand study documents and computer assisted interview without any translation Exclusion Criteria: * Individuals who are not able to visit the study center due to psychological or physical impairment * STEMI within the last 4 months, NSTEMI within the last 3 months * Acute decompensated heart failure * Surgery, especially coronary artery bypass grafting within the last 3 months * Acute disease, especially acute infectious disease, endocarditis, myocarditis or pericarditis

Primary outcome measure(s)

Trial sites (1)

FacilityCityRegionStatus
University Medical Center of the Johannes Gutenberg-University Mainz Mainz Rhineland-Palatinate

More Johannes Gutenberg University Mainz trials in Germany

Other trials for the same condition

Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT04064450 on ClinicalTrials.gov ↗ ← All trials in Germany